Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · IEX Real-Time Price · USD
17.60
+0.16 (0.92%)
At close: Jul 12, 2024, 4:00 PM
17.73
+0.13 (0.74%)
After-hours: Jul 12, 2024, 7:53 PM EDT

Lexeo Therapeutics Statistics

Total Valuation

LXEO has a market cap or net worth of $579.84 million. The enterprise value is $392.76 million.

Market Cap 579.84M
Enterprise Value 392.76M

Important Dates

The next estimated earnings date is Wednesday, August 21, 2024, after market close.

Earnings Date Aug 21, 2024
Ex-Dividend Date n/a

Share Statistics

LXEO has 32.95 million shares outstanding. The number of shares has increased by 1,637.02% in one year.

Shares Outstanding 32.95M
Shares Change (YoY) +1,637.02%
Shares Change (QoQ) +422.56%
Owned by Insiders (%) 5.63%
Owned by Institutions (%) 86.18%
Float 14.26M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 3.17
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.16, with a Debt / Equity ratio of 0.06.

Current Ratio 9.16
Quick Ratio n/a
Debt / Equity 0.06
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -360.55

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -58.70%
Return on Capital (ROIC) -37.34%
Revenue Per Employee n/a
Profits Per Employee -$1.20M
Employee Count 58
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 15.54
200-Day Moving Average n/a
Relative Strength Index (RSI) 58.55
Average Volume (20 Days) 304,611

Short Selling Information

The latest short interest is 775,621, so 2.35% of the outstanding shares have been sold short.

Short Interest 775,621
Short Previous Month 628,823
Short % of Shares Out 2.35%
Short % of Float 5.44%
Short Ratio (days to cover) 0.35

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -72.51M
Pretax Income -69.42M
Net Income -69.42M
EBITDA n/a
EBIT -69.23M
Earnings Per Share (EPS) -$1.59
Full Income Statement

Balance Sheet

The company has $198.31 million in cash and $11.24 million in debt, giving a net cash position of $187.08 million or $5.68 per share.

Cash & Cash Equivalents 198.31M
Total Debt 11.24M
Net Cash 187.08M
Net Cash Per Share $5.68
Equity (Book Value) 182.95M
Book Value Per Share 5.55
Working Capital 176.46M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

LXEO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1,637.02%
Shareholder Yield -1,637.02%
Earnings Yield -11.97%
FCF Yield n/a

Analyst Forecast

The average price target for LXEO is $22.29, which is 26.65% higher than the current price. The consensus rating is "Strong Buy".

Price Target $22.29
Price Target Difference 26.65%
Analyst Consensus Strong Buy
Analyst Count 7
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -26.85%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a